Availability of biologics in Europe (as of April 2021)
| Country | Number of available biologics | Omalizumab | Mepolizumab | Reslizumab | Benralizumab | Dupilumab |
| Austria | 5 | 1 | 1 | 1 | 1 | 1 |
| Belgium | 4 | 1 | 1 | 1 | 1 | 0 |
| Croatia | 4 | 1 | 1 | 1 | 1 | 0 |
| Czech Republic | 5 | 1 | 1 | 1 | 1 | 1 |
| Denmark | 5 | 1 | 1 | 1 | 1 | 1 |
| Estonia | 5 | 1 | 1 | 1 | 1 | 1 |
| Finland | 5 | 1 | 1 | 1 | 1 | 1 |
| France | 5 | 1 | 1 | 1 | 1 | 1 |
| Germany | 5 | 1 | 1 | 1 | 1 | 1 |
| Greece | 2 | 1 | 1 | 0 | 0 | 0 |
| Hungary | 5 | 1 | 1 | 1 | 1 | 1 |
| Iceland | 5 | 1 | 1 | 1 | 1 | 1 |
| Ireland | 4 | 1 | 1 | 1 | 1 | 0 |
| Italy | 3 | 1 | 1 | 0 | 1 | 0 |
| Latvia | 5 | 1 | 1 | 1 | 1 | 1 |
| Lithuania | 3 | 1 | 1 | 0 | 1 | 0 |
| Netherlands | 5 | 1 | 1 | 1 | 1 | 1 |
| Poland | 3 | 1 | 1 | 0 | 1 | 0 |
| Portugal | 5 | 1 | 1 | 1 | 1 | 1 |
| Romania | 2 | 1 | 0 | 0 | 1 | 0 |
| Russia | 5 | 1 | 1 | 1 | 1 | 1 |
| Serbia | 3 | 1 | 0 | 1 | 1 | 0 |
| Slovenia | 4 | 1 | 1 | 1 | 1 | 0 |
| Spain | 5 | 1 | 1 | 1 | 1 | 0 |
| Sweden | 5 | 1 | 1 | 1 | 1 | 1 |
| Switzerland | 5 | 1 | 1 | 1 | 1 | Off label |
| Turkey | 2 | 1 | 1 | 0 | 0 | 0 |
| UK | 5 | 1 | 1 | 1 | 1 | 1 |
Of note, this table summarises the availability of biologics at the time the survey was conducted (November 2020 to April 2021). Since survey completion, dupilumab has become available in Spain, Switzerland, Croatia and Slovenia.